David Edward Clark

6PUBLICATIONS
36CO-AUTHORS
Medical infection agents (incl. prions)Medical devicesProteins and peptidesHaematologyComputational chemistry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 21, 2026
Pharmacological inhibition of PMS2 induces MMR deficiency and response to immune checkpoint blockade.

|Feb 20, 2026
A Journey through Scaffolds: Indolines, Pyrrolidines, and Azetidines in the Quest for Inhaled DDR Inhibitors for IPF.

Laura Carzaniga, Fabio Rancati, Andrea Rizzi

|Oct 30, 2025
Correction to "Sebetralstat (KVD900): A Potent and Selective Small Molecule Plasma Kallikrein Inhibitor Featuring a Novel P1 Group as a Potential Oral On-Demand Treatment for Hereditary Angioedema".

Rebecca L Davie, Hannah J Edwards, D Michael Evans

|Oct 17, 2022
Sebetralstat (KVD900): A Potent and Selective Small Molecule Plasma Kallikrein Inhibitor Featuring a Novel P1 Group as a Potential Oral On-Demand Treatment for Hereditary Angioedema.

Rebecca L Davie, Hannah J Edwards, D Michael Evans

|May 29, 2020
Virtual Screening: Is Bigger Always Better? Or Can Small Be Beautiful?

David E Clark

|Feb 08, 2019
Automated De Novo Drug Design: Are We Nearly There Yet?

Gisbert Schneider, David E Clark

Pageof 1

Frequent Collaborators

2 joint publications

Michael J Stocks

2 joint publications

Michael B Roe

2 joint publications

Marta Giuliani

1 joint publications

Gisbert Schneider